Literature DB >> 9824511

Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta.

S Ishizaka1, M Kimoto, S Kanda, S Saito.   

Abstract

The latent form of transforming growth factor-beta (TGF-beta) in human milk and platelets was converted to the active form when conscious, pylorus-ligated mice were given human milk and platelets by intragastric intubation. Oral administration of TGF-beta exerted enhancing effects on the natural killer (NK)-cell activities in spleen and liver. Augmentation of NK-cell activities in spleen was observed for 7 days after oral administration of TGF-beta. TGF-beta at concentrations of 5 and 20 ng produced the greatest augmentation of NK-cell activities in spleen. However, NK-cell activities in spleen were unaffected when TGF-beta was given intravenously. Interleukin (IL)-12 production in spleen was enhanced by oral administration of TGF-beta, but not by intravenous administration of TGF-beta. These findings suggest that large amounts of TGF-beta in human milk are involved in early antiviral protection through the augmentation of NK-cell activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824511      PMCID: PMC1364414          DOI: 10.1046/j.1365-2567.1998.00652.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  What is the role of cytokines in human colostrum?

Authors:  V Bocci; K von Bremen; F Corradeschi; E Luzzi; L Paulesu
Journal:  J Biol Regul Homeost Agents       Date:  1991 Oct-Dec       Impact factor: 1.711

2.  Immunoregulatory effects of transforming growth factor-beta in a prolonged period of culture.

Authors:  S Ishizaka; M Yoshikawa; T Tsujii
Journal:  Cell Immunol       Date:  1992-01       Impact factor: 4.868

3.  Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

Authors:  M C Kuppner; M F Hamou; Y Sawamura; S Bodmer; N de Tribolet
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115

4.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

Authors:  M D O'Connor-McCourt; L M Wakefield
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

5.  Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta.

Authors:  S S Huang; P O'Grady; J S Huang
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

6.  Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta.

Authors:  M R Shalaby; A J Ammann
Journal:  Cell Immunol       Date:  1988-04-01       Impact factor: 4.868

7.  Transforming growth factor-beta 1 is a costimulator for IgA production.

Authors:  P H Kim; M F Kagnoff
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

8.  Detection of IL-6 in human milk and its involvement in IgA production.

Authors:  S Saito; M Maruyama; Y Kato; I Moriyama; M Ichijo
Journal:  J Reprod Immunol       Date:  1991-09       Impact factor: 4.054

9.  Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes.

Authors:  R L Coffman; D A Lebman; B Shrader
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.

Authors:  T Espevik; I S Figari; M R Shalaby; G A Lackides; G D Lewis; H M Shepard; M A Palladino
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  1 in total

1.  Effects of exogenous transforming growth factor beta on Trypanosoma congolense infection in mice.

Authors:  Boniface Namangala; Chihiro Sugimoto; Noboru Inoue
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.